The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:

Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer

CME Available: auau.auanet.org/node/39487

Release Date: December, 2023

Expiration Date: December, 2024

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

1. Identify the indications for germline testing in prostate cancer patients.

2. Explain how germline testing is used to identify genetic mutations in genitourinary (GU) cancers, specifically focusing on prostate cancer.

3. Analyze the potential advantages and challenges associated with using germline testing and targeted therapies in the management of prostate cancer.

ACKNOWLEDGEMENTS:

Support provided by independent educational grants from:

Astellas and Pfizer, Inc

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lantheus Medical Imaging

Merck & Co., Inc.